XML 46 R34.htm IDEA: XBRL DOCUMENT
v3.23.1

Commitments and contingencies (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2023
Commitments and Contingencies Disclosure [Abstract] |
Schedule Of Material Details Of Individual Settlements |
Date |  | Jurisdiction |  | Settlement Payment * |  | Payment Term |  | Settlement Product |  | Product WAC Value and Term
June 7, 2019 |  | Oklahoma |  | $72.3 million (paid) |  | 1 year |  | N/A |  | N/A
December 27, 2019 |  | Cuyahoga County, OH |  | $12.4 million (paid) |  | 2.5 years |  | buprenorphine naloxone (generic Suboxone ® ) |  | $15.5 million (3 years)
December 27, 2019 |  | Summit County, OH |  | $7.6 million (paid) |  | 2.5 years |  | buprenorphine naloxone (generic Suboxone ® ) |  | $9.5 million (3 years)
January 18, 2022 |  | Louisiana |  | $15 million |  | 18 years |  | buprenorphine naloxone (generic Suboxone ® ) |  | $3 million (1 year)
February 4, 2022 |  | Texas |  | $131.5 million |  | 15 years |  | naloxone hydrochloride (generic Narcan®) |  | $75 million (10 years)
March 21, 2022 |  | Rhode Island |  | $21 million |  | 13 years |  | naloxone hydrochloride (generic Narcan ® ) and buprenorphine naloxone (generic Suboxone ® ) |  | $78.5 million (10 years)
March 30, 2022 |  | Florida |  | $177.1 million |  | 15 years |  | naloxone hydrochloride (generic Narcan®) |  | $84 million (10 years)
July 12, 2022 |  | San Francisco |  | $19.5 million |  | 13 years |  | naloxone hydrochloride (generic Narcan®) |  | $20 million (10 years)
September 19, 2022 |  | West Virginia |  | $75.4 million |  | 15 years |  | naloxone hydrochloride (generic Narcan®) |  | $27 million (10 years)
November 3, 2022 |  | New York |  | $313.3 million ** |  | 18 years |  | N/A |  | N/A
February 24, 2023 |  | Tribes |  | $108.3 million |  | 13 years |  | naloxone hydrochloride (generic Narcan®) |  | $25 million (10 years)
* | Amounts exclude attorneys’ fees and costs, except New York.
** | Not including cash payment and attorneys’ fees allocated under the nationwide settlement.

X
- References No definition available. + Details
Name: | us-gaap_CommitmentsAndContingenciesDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the loss contingencies that were reported in the period or disclosed as of the balance sheet date. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 450 -SubTopic 20 -Section 50 -Paragraph 4 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 450 -SubTopic 20 -Section 50 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 460 -SubTopic 10 -Section 50 -Paragraph 2 -URI https://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 460 -SubTopic 10 -Section 50 -Paragraph 3 -URI https://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248 Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 450 -SubTopic 20 -Section 50 -Paragraph 9 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349 + Details
Name: | us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration